236 related articles for article (PubMed ID: 23460324)
1. Bevacizumab treatment of symptomatic pseudoprogression after boron neutron capture therapy for recurrent malignant gliomas. Report of 2 cases.
Miyatake S; Furuse M; Kawabata S; Maruyama T; Kumabe T; Kuroiwa T; Ono K
Neuro Oncol; 2013 Jun; 15(6):650-5. PubMed ID: 23460324
[TBL] [Abstract][Full Text] [Related]
2. Boron neutron capture therapy with bevacizumab may prolong the survival of recurrent malignant glioma patients: four cases.
Miyatake S; Kawabata S; Hiramatsu R; Furuse M; Kuroiwa T; Suzuki M
Radiat Oncol; 2014 Jan; 9():6. PubMed ID: 24387301
[TBL] [Abstract][Full Text] [Related]
3. Boron neutron capture therapy and add-on bevacizumab in patients with recurrent malignant glioma.
Furuse M; Kawabata S; Wanibuchi M; Shiba H; Takeuchi K; Kondo N; Tanaka H; Sakurai Y; Suzuki M; Ono K; Miyatake SI
Jpn J Clin Oncol; 2022 May; 52(5):433-440. PubMed ID: 35079791
[TBL] [Abstract][Full Text] [Related]
4. Boron Neutron Capture Therapy of Malignant Gliomas.
Miyatake SI; Kawabata S; Hiramatsu R; Kuroiwa T; Suzuki M; Ono K
Prog Neurol Surg; 2018; 32():48-56. PubMed ID: 29990973
[TBL] [Abstract][Full Text] [Related]
5. Pseudoprogression in boron neutron capture therapy for malignant gliomas and meningiomas.
Miyatake S; Kawabata S; Nonoguchi N; Yokoyama K; Kuroiwa T; Matsui H; Ono K
Neuro Oncol; 2009 Aug; 11(4):430-6. PubMed ID: 19289492
[TBL] [Abstract][Full Text] [Related]
6. Boron Neutron Capture Therapy Combined with Early Successive Bevacizumab Treatments for Recurrent Malignant Gliomas - A Pilot Study.
Shiba H; Takeuchi K; Hiramatsu R; Furuse M; Nonoguchi N; Kawabata S; Kuroiwa T; Kondo N; Sakurai Y; Suzuki M; Ono K; Oue S; Ishikawa E; Michiue H; Miyatake SI
Neurol Med Chir (Tokyo); 2018 Dec; 58(12):487-494. PubMed ID: 30464150
[TBL] [Abstract][Full Text] [Related]
7. Modified boron neutron capture therapy for malignant gliomas performed using epithermal neutron and two boron compounds with different accumulation mechanisms: an efficacy study based on findings on neuroimages.
Miyatake S; Kawabata S; Kajimoto Y; Aoki A; Yokoyama K; Yamada M; Kuroiwa T; Tsuji M; Imahori Y; Kirihata M; Sakurai Y; Masunaga S; Nagata K; Maruhashi A; Ono K
J Neurosurg; 2005 Dec; 103(6):1000-9. PubMed ID: 16381186
[TBL] [Abstract][Full Text] [Related]
8. Boron neutron capture therapy for recurrent high-grade meningiomas.
Kawabata S; Hiramatsu R; Kuroiwa T; Ono K; Miyatake S
J Neurosurg; 2013 Oct; 119(4):837-44. PubMed ID: 23808536
[TBL] [Abstract][Full Text] [Related]
9. Survival benefit of boron neutron capture therapy for recurrent malignant gliomas.
Miyatake S; Kawabata S; Yokoyama K; Kuroiwa T; Michiue H; Sakurai Y; Kumada H; Suzuki M; Maruhashi A; Kirihata M; Onoc K
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S22-4. PubMed ID: 19394240
[TBL] [Abstract][Full Text] [Related]
10. Rescue bevacizumab following symptomatic pseudoprogression of a tectal glioma post-radiotherapy: a case report and review of the literature.
Nguyen TK; Perry J; Sundaram ANE; Detsky J; Maralani PJ; Calabrese E; Das S; Sahgal A
J Neurooncol; 2019 Jul; 143(3):475-481. PubMed ID: 31054097
[TBL] [Abstract][Full Text] [Related]
11. Repeated treatments with bevacizumab for recurrent radiation necrosis in patients with malignant brain tumors: a report of 2 cases.
Furuse M; Kawabata S; Kuroiwa T; Miyatake S
J Neurooncol; 2011 May; 102(3):471-5. PubMed ID: 20694573
[TBL] [Abstract][Full Text] [Related]
12. Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence.
Norden AD; Young GS; Setayesh K; Muzikansky A; Klufas R; Ross GL; Ciampa AS; Ebbeling LG; Levy B; Drappatz J; Kesari S; Wen PY
Neurology; 2008 Mar; 70(10):779-87. PubMed ID: 18316689
[TBL] [Abstract][Full Text] [Related]
13. Survival benefit of Boron neutron capture therapy for recurrent malignant gliomas.
Miyatake S; Kawabata S; Yokoyama K; Kuroiwa T; Michiue H; Sakurai Y; Kumada H; Suzuki M; Maruhashi A; Kirihata M; Ono K
J Neurooncol; 2009 Jan; 91(2):199-206. PubMed ID: 18813875
[TBL] [Abstract][Full Text] [Related]
14. Re-irradiation with and without bevacizumab as salvage therapy for recurrent or progressive high-grade gliomas.
Hundsberger T; Brügge D; Putora PM; Weder P; Weber J; Plasswilm L
J Neurooncol; 2013 Mar; 112(1):133-9. PubMed ID: 23314822
[TBL] [Abstract][Full Text] [Related]
15. Boron Neutron Capture Therapy in the Treatment of Recurrent Laryngeal Cancer.
Haapaniemi A; Kankaanranta L; Saat R; Koivunoro H; Saarilahti K; Mäkitie A; Atula T; Joensuu H
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):404-410. PubMed ID: 26797537
[TBL] [Abstract][Full Text] [Related]
16. Boron neutron capture therapy for malignant brain tumors.
Miyatake SI; Wanibuchi M; Hu N; Ono K
J Neurooncol; 2020 Aug; 149(1):1-11. PubMed ID: 32676954
[TBL] [Abstract][Full Text] [Related]
17. Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas.
Brandsma D; Stalpers L; Taal W; Sminia P; van den Bent MJ
Lancet Oncol; 2008 May; 9(5):453-61. PubMed ID: 18452856
[TBL] [Abstract][Full Text] [Related]
18. Drug review: Safety and efficacy of bevacizumab for glioblastoma and other brain tumors.
Narita Y
Jpn J Clin Oncol; 2013 Jun; 43(6):587-95. PubMed ID: 23585688
[TBL] [Abstract][Full Text] [Related]
19. Radiation injury of boron neutron capture therapy using mixed epithermal- and thermal neutron beams in patients with malignant glioma.
Kageji T; Nagahiro S; Mizobuchi Y; Toi H; Nakagawa Y; Kumada H
Appl Radiat Isot; 2004 Nov; 61(5):1063-7. PubMed ID: 15308193
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas.
Gutin PH; Iwamoto FM; Beal K; Mohile NA; Karimi S; Hou BL; Lymberis S; Yamada Y; Chang J; Abrey LE
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):156-63. PubMed ID: 19167838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
